Beyond Air (XAIR) Capital Expenditures Growth (3y) (2020 - 2026)
Beyond Air (XAIR) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.15% |
| 10 | Beyond Air | 2.23 Mn | -10.13 Mn | 94,000.00 | -26.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.82% |
| Dec 31, 2025 | -62.29% |
| Sep 30, 2025 | -36.55% |
| Jun 30, 2025 | -8.45% |
| Mar 31, 2025 | -139.07% |
| Dec 31, 2024 | 8.62% |
| Sep 30, 2024 | 25.67% |
| Jun 30, 2024 | 362.61% |
| Mar 31, 2024 | 358.76% |
| Dec 31, 2023 | 112.67% |
| Sep 30, 2023 | 51.11% |
| Jun 30, 2023 | 48.35% |
| Mar 31, 2023 | 408.45% |
| Dec 31, 2022 | 292.16% |
| Sep 30, 2022 | 303.82% |
| Jun 30, 2022 | 336.04% |
| Mar 31, 2022 | 332.89% |
| Dec 31, 2021 | 198.38% |
| Mar 31, 2021 | 171.44% |
| Dec 31, 2020 | -14.09% |